Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03691493
Title Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis (ASPIRE)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Emory University

Her2-receptor negative breast cancer


Letrozole + Palbociclib

Palbociclib + Tamoxifen

Fulvestrant + Palbociclib

Anastrozole + Palbociclib

Exemestane + Palbociclib

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.